CD36 and Insulin resistance: Insulin resistance in WAT favors triacylglycerol lipolysis, thus leading to a massive release, into the circulation, of glycerol and non-esterified fatty acids (NEFAs), which enter the liver in a concentration-dependent manner via transporters such as the fatty acid translocase (FAT/CD36) and different fatty acid transport proteins (FATPs).